Skip to main content

Table 6 The association of demographic, gynecologic/obstetrics factors and PMS symptoms with the use of PMS treatments, March-April, 2013 (n = 173)

From: Prevalence, impacts and medical managements of premenstrual syndrome among female students: cross-sectional study in college of health sciences, Mekelle University, Mekelle, Northern Ethiopia

Variables

Use of PMS treatments

X 2

P-value

Marital status

8.603

.072

Class year in university

4.735

.316

Department

7.818

.252

Residence

.365

.833

Chronic disease

.271

.603

Past contraceptive use

.937

.333

Number of year of contraceptive use

2.000

.157

Age of first menstruation

6.782

.079

Average length of one cycle of menstruation

2.104

.551

Number of days of bleeding per one cycle

9.438

.024*

Menstrual flow type

4.636

.200

Academic performance impairment

13.764

.000*

Type of performance impairment

1.157

.763

Abdominal bloating

5.190

.637

Breast tenderness

3.992

.551

Generalized body pain

2.412

.878

Headache

8.273

.309

Back pain

5.559

.592

Weight gain

7.803

.253

Weight loss

6.021

.304

Eating more than usual

5.546

.594

Shortness of breath

6.183

.519

Abdominal cramp

6.671

.464

Weakness

.712

.982

Vomiting

4.265

.512

Difficulty concentrating

5.738

.333

Sleep loss

5.438

.489

Forgetfulness

5.502

.358

Craving for sweet foods and alcohol

8.677

.277

Depressed mood

10.232

.176

Loss of interest in doing things

3.295

.856

Anger

11.306

.185

  1. Those denoted as ’*’ are said to have association with the use of PMS treatment for p < 0.05.